Trans-cinnamaldehyde-Biosurfactant Complex as a Potent Agent against Enterococcus faecalis Biofilms

Mingxin Hu1, Shanthini Kalimuthu1, Chengfei Zhang1

  • 1Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.

Pharmaceutics
|November 11, 2022
PubMed

Insights

trans-cinnamaldehyde complexed with acidic sophorolipid effectively eradicates Enterococcus faecalis biofilms. This novel formulation overcomes the limitations of trans-cinnamaldehyde alone, offering a promising strategy against persistent bacterial infections.

Area of Science:

  • Microbiology
  • Biotechnology
  • Infectious Diseases

Background:

  • Enterococcus faecalis is an opportunistic pathogen causing various infections.
  • E. faecalis forms robust biofilms resistant to antibiotics.
  • Developing new anti-biofilm strategies is crucial.

Purpose of the Study:

  • To evaluate the efficacy of a trans-cinnamaldehyde (TC) and acidic sophorolipid (ASL) complex against E. faecalis biofilms.
  • To address the clinical translation challenges posed by TC's hydrophobicity.

Main Methods:

  • Treatment of E. faecalis biofilms with TC-ASL complex.
  • Assessment of bacterial viability and biomass reduction.
  • Confocal laser-scanning microscopy to analyze biofilm structure.

Main Results:

  • The TC-ASL complex significantly reduced E. faecalis biofilm viability and biomass compared to TC alone.
  • Microscopic analysis showed decreased biofilm thickness and volume after TC-ASL treatment.
  • The complex improved upon the anti-biofilm activity of TC.

Conclusions:

  • The novel TC-ASL complex demonstrates significant anti-biofilm potential against E. faecalis.
  • This formulation offers a promising alternative for treating E. faecalis biofilm infections.
  • The study highlights the therapeutic potential of combining natural compounds with biosurfactants.